Canaccord Genuity Starts Pulmonx Corp. (LUNG) at Buy

Canaccord Genuity analyst William Plovanic initiates coverage on Pulmonx Corp. (NASDAQ: LUNG) with a Buy rating and a price target of $49.00.

For an analyst ratings summary and ratings history on Pulmonx Corp. click here. For more ratings news on Pulmonx Corp. click here.

Shares of Pulmonx Corp. closed at $42.24 yesterday.

You May Also Be Interested In

• ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
• Lake Street Starts RF Industries Ltd. (RFIL) at Buy
• Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy